Aspirin

(redirected from Bayer Aspirin)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.

Aspirin

Australian Stock Price Riskless Indexed Notes. Zero-coupon four-year bonds repayable at face value plus the percentage increase by which the Australian stock index of all ordinaries (common stocks) rises above a predefined level during the given period.

Aspirin

Australian Stock Price Riskless Index Note. A debt security with no coupon with a return based on the return of a benchmark stock index. Unlike most zero-coupon bonds, an Aspirin is issued at face value; however, like others, it is redeemed at face value at maturity, which is four years after issue. The return (or the equivalent of a coupon) on an Aspirin is the fact that the bondholder receives a percentage of the return on the Australian all-ordinaries stock index provided it is over a certain amount. For example, if the limit is 5% and the return is 9% over the four years of the Aspirin, the bondholder receives a return of 4%. However, if the return on the all-ordinaries index falls below the limit, the bondholder receives no return. Aspirins allow investors to participate in the stock market without assuming all of the risk involved.
Mentioned in ?
References in periodicals archive ?
In January 1899, they introduced acetylsalicyclic acid, better known by its brand name "Aspirin." Bayer Aspirin remains one of the world's best-selling over-the-counter remedies 100 years later.
Bayer Aspirin with Heart Advantage--due to the confusion it might cause.
Customers could pick between a 200-count Bayer Aspirin and 100-caplet Motrin for $6.99.
Although best known for its flagship product, Bayer Aspirin, Bayer Corporation produces a broad range of health care, life sciences, and chemical products that help diagnose and treat diseases, purify water, preserve local landmarks, protect crops, advance automobile safety and durability, and improve people's lives.
Sales gains from Nyquil, Dayquil, Metamucil and Align helped lift Procter & Gamble Co.'s O-T-C sales 4.5%; Bayer Consumer Healthcare's O-T-C sales experienced 4% growth in 2011 based on gains of One A Day, Aleve, Bayer Aspirin and Alka-Seltzer.
The American Herbal Products Association (AHPA), Silver Spring, MD, requested that FDA clarify its policy on over-the-counter (OTC) drug and dietary supplement combination products to avoid confusion among companies and consumers, following the recent launch of Bayer Healthcare's (Wayne, NJ) new analgesic phytosterol supplement, Bayer Aspirin With Heart Advantage, which contains 81 mg of aspirin and 400 mg of phytosterols.
Whitehall-Robins Healthcare ranks second with Advil, followed by Bayer with Aleve and Bayer aspirin. Bristol-Myers Squibb gave its Excedrine brand a boost last year with the introduction of Excedrine QuickTabs.
Leading brands in the United States include Bayer Aspirin, Aleve, Alka-Seltzer Plus, Bactine, Citracal, RID, Phillips' Milk of Magnesia, Phillips' Colon Health, Midol, Alka-Seltzer, and One A Day, One A Day Women's Prenatal and Flintstones vitamins.
The company's flagship product, Bayer Aspirin, is marching forward with two important initiatives.
Marketers say the product is clinically proven to relieve tough pain twice as fast as previous Bayer Aspirin tablets.
The Bayer Aspirin brand also outperformed the category in 2000, a showing the company credits to the brand's positioning as "the only branded O-T-C pain reliever that provides powerful pain relief and lifesaving benefits." This "added-value strategy" has been responsible for a nearly 50% increase in Bayer Aspirin's U.S.
Some of its brands include Bayer Aspirin, Aleve, Alka Seltzer, Alka Seltzer Plus, Bactine, Citracal, RID, Phillips' Milk of Magnesia, Midol and One A Day Flintstones vitamins.